Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace(National Institutes of Health), Robert M. Johnson(University of Maryland, Baltimore), Venkata Viswanadh Edara(Emory University), Bart L. Haagmans(Erasmus MC), Adolfo García‐Sastre(Office of Infectious Diseases), Tamarand L. Darling(Washington University in St. Louis), Adam Godzik(University of California, Riverside), Christian Drosten(Humboldt-Universität zu Berlin), Bethany L. Dearlove(Cambridge School), Arghavan Alisoltani(Northwestern University), Juan Manuel Carreño(Icahn School of Medicine at Mount Sinai), Aubree Gordon(University of Michigan), Gaston Bonenfant(Centers for Disease Control and Prevention), Ralph S. Baric(University of North Carolina at Chapel Hill), Adrianus C. M. Boon, Eli Boritz(National Institutes of Health), Ali H. Ellebedy(Washington University in St. Louis), Debbie Bratt(National Institutes of Health), Will Fischer(Los Alamos National Laboratory), Liel Cohen-Lavi(Ben-Gurion University of the Negev), Ron A. M. Fouchier(Erasmus MC), Matthew B. Frieman(University of Maryland, Baltimore), Rama Rao Amara(Emory University), Daniel C. Douek(Institut de Recherche Vaccinale), Meike Dittmann(New York University), Traci L. Bricker(Washington University in St. Louis), David D. Ho(Columbia University), Trushar Jeevan(St. Jude Children's Research Hospital), Sarah L. James(University of Cambridge), Guido Ferrari(Duke University), William C. Florence(Vanderbilt University), Yaoxing Huang(Aaron Diamond AIDS Research Center), Dan H. Barouch(Beth Israel Deaconess Medical Center), Louis-Marie Bloyet(Washington University in St. Louis), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Ana S. Gonzalez‐Reiche(Icahn School of Medicine at Mount Sinai), Lukasz Jaroszewski(University of California, Riverside), William Buchser(James S. McDonnell Foundation), Florian Krammer(Semmelweis University), Peter Halfmann(University of Wisconsin–Madison), Elodie Ghedin(National Institutes of Health), Alba Grifoni(La Jolla Institute for Immunology), Nicole A. Doria‐Rose(National Institutes of Health), Thomas Fabrizio(St. Jude Children's Research Hospital), Jesse D. Bloom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Liliana Brown(National Institutes of Health), Han Di(Centers for Disease Control and Prevention), Michael R. Holbrook(National Institutes of Health), John Franks(St. Jude Children's Research Hospital), Meredith E. Davis-Gardner(Emory University)
Cited by 185
Related Papers
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
|New England Journal of Medicine|2012|6k
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k